Home
About
Overview
Sharing Data
ORCID
Help
History (78)
Periventricular Nodular Heterotopia
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
Racial disparities in reaching the renal transplant waitlist: is geography as important as race?
Coformycin
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
See All 78 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med. 2012 Oct 18; 367(16):1519-28.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Crohn Disease
Double-Blind Method
Drug Resistance
Female
Humans
Induction Chemotherapy
Maintenance Chemotherapy
Male
Middle Aged
Remission Induction
Severity of Illness Index
Ustekinumab
authors with profiles
Stephen B. Hanauer